These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12648730)

  • 1. Increased phospholipase A2 activity in schizophrenia with absent response to niacin.
    Tavares H; Yacubian J; Talib LL; Barbosa NR; Gattaz WF
    Schizophr Res; 2003 May; 61(1):1-6. PubMed ID: 12648730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia.
    Hudson C; Gotowiec A; Seeman M; Warsh J; Ross BM
    Biol Psychiatry; 1999 Aug; 46(3):401-5. PubMed ID: 10435206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma phospholipase-A2 activity in schizophrenic patients: reduction after neuroleptic therapy.
    Gattaz WF; Köllisch M; Thuren T; Virtanen JA; Kinnunen PK
    Biol Psychiatry; 1987 Apr; 22(4):421-6. PubMed ID: 3567258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia].
    Gattaz WF; Nevalainen TJ; Kinnunen PK
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):148-53. PubMed ID: 2354835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid and eicosanoid signaling disturbances in schizophrenia.
    Ross BM
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):407-12. PubMed ID: 14623494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
    Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
    Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.
    Barbosa NR; Junqueira RM; Vallada HP; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):340-3. PubMed ID: 17629734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis].
    Gattaz WF; Brunner J; Schmitt A; Maras A
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):489-96. PubMed ID: 7835820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased platelet phospholipase A2 activity in schizophrenia.
    Gattaz WF; Schmitt A; Maras A
    Schizophr Res; 1995 Jul; 16(1):1-6. PubMed ID: 7547640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of phospholipases A2 in schizophrenia.
    Law MH; Cotton RG; Berger GE
    Mol Psychiatry; 2006 Jun; 11(6):547-56. PubMed ID: 16585943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.
    Ross BM; Hudson C; Erlich J; Warsh JJ; Kish SJ
    Arch Gen Psychiatry; 1997 May; 54(5):487-94. PubMed ID: 9152103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia.
    Xu C; Yang X; Sun L; Yang T; Cai C; Wang P; Jiang J; Qing Y; Hu X; Wang D; Wang P; Cui G; Zhang J; Li Y; Ji F; Liu C; Wan C
    Psychiatry Res; 2019 Mar; 273():782-787. PubMed ID: 31207866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niacin skin flush test: a research tool for studying schizophrenia.
    Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
    Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase A2 and the hypofrontality hypothesis of schizophrenia.
    Gattaz WF; Brunner J
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):109-13. PubMed ID: 8888132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
    Nilsson BM; Hultman CM; Wiesel FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.
    Ross BM; Turenne S; Moszczynska A; Warsh JJ; Kish SJ
    Brain Res; 1999 Mar; 821(2):407-13. PubMed ID: 10064828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.
    Smesny S; Kinder D; Willhardt I; Rosburg T; Lasch J; Berger G; Sauer H
    Biol Psychiatry; 2005 Feb; 57(4):399-405. PubMed ID: 15705356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebral injection of phospholipase A2 inhibits dopamine-mediated behavior in rats: possible implications for schizophrenia.
    Brunner J; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):13-6. PubMed ID: 8773214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated PLA2 activity in schizophrenics and other psychiatric patients.
    Noponen M; Sanfilipo M; Samanich K; Ryer H; Ko G; Angrist B; Wolkin A; Duncan E; Rotrosen J
    Biol Psychiatry; 1993 Nov; 34(9):641-9. PubMed ID: 8292693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.